Peripheral or Axial Bone Density Measurements to Identify Osteoporosis in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy?

Urology

Volumn 73, Issue 6, 2009, Pages 1347-1351

  Wadhwa, Vivek K ^a   Parr, Nigel J ^a  

^a WIRRAL UNIVERSITY TEACHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE DENSITOMETRY; CALCIFICATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSTATIC NEOPLASMS;

EID: 67349224104     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.055     Document Type: Article

References (24)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., et al. Cancer statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Daniell H.W. Osteoporosis after orchidectomy for prostate cancer. J Urol 157 (1997) 439-444
3. Hussain S.A., Weston R., Stephenson R.N., et al. Immediate dual energy x-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation. BJU Int 92 (2003) 690-694
4. Oefelein M.G., Ricchiuti V., Conran W., et al. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 168 (2002) 1005-1007
5. Diamond T.H., Higano C.S., Smith M.R., et al. Osteoporosis in men with prostate carcinoma receiving androgen deprivation therapy: recommendations for diagnosis and therapies. Cancer 100 (2004) 892-899
6. Melton III L.J., Atkinson E.J., O'Connor M.K., et al. Bone density and fracture risk in men. J Bone Miner Res 13 (1998) 1915-1923
7. Looker A.C., Wahner H.W., Dunn W.L., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8 (1998) 468-489
8. World Health Organization. Technical report series 843: assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994), World Health Organisation, Geneva
9. Roberts S., and Goldacre M.J. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. BMJ 327 (2003) 771-775
10. Clarke N.W., McClure J., and George N.J.R. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 68 (1991) 74-80
11. Smith M.R., McGovern F.J., Zietman A.L., et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 345 (2001) 948-955
12. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
13. De Lacet C.E., Van Hout B.A., Burger H., et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res 13 (1998) 1587-1593
14. Düppe H., Gärdsell P., Nilsson B., et al. A single bone density measurement can predict fractures over 25 years. Calcif Tissue Int 60 (1997) 171-174
15. Nyquist F., Gärdsell P., Sernbo I., et al. Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: a prospective population-based study. Bone 22 (1998) 147-151
16. Mittan D., Lee S., Miller E., et al. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87 (2002) 3656-3661
17. Mellström D., Johnell O., Ljunggren O., et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21 (2006) 529-535
18. Jones G., Nguyen T., Sambrook P.N., et al. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol 22 (1995) 932-936
19. Mole P.A., McMurdo M.E.T., and Patterson C.R. Evaluation of peripheral dual energy x-ray absorptiometry: comparison with single photon absorptiometry of the forearm and dual energy x-ray absorptiometry of the spine or femur. Br J Radiol 71 (1998) 427-432
20. Shahinian V.B., Kuo Y.F., Freeman J.L., et al. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352 (2005) 154-164
21. Van der Klift M., DeLaet C.E., McCloskey E.V., et al. The incidence of vertebral fractures in men and women: The Rotterdam study. J Bone Miner Res 17 (2002) 1051-1056
22. Lu Y., Genant H.K., Shepherd J., et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res 16 (2001) 901-910
23. Bae D.C., Leocárdio D.E., and Stein B.S. A comparison of dual energy x-ray absorptiometry of the hip and accuDEXA of the finger for the diagnosis of osteoporosis in men on androgen deprivation therapy for advanced prostate cancer. Prostate Cancer Prostatic Dis 10 (2007) 94-96
24. Bruder J.M., Ma J.Z., Basler J.W., et al. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen deprivation therapy. Urology 67 (2006) 152-155